ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics

ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales DANONE Invests in Market Leading Chinese Fruit Juice Company Company announces that it has acquired 22.18% of the Chinese fruit beverages company China Hui Yuan Juice Holdings Co., Ltd Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Health Sciences Group Appoints New CEO Company's Board of Directors has appointed Stuart Gold as its Chief Executive Officer. Health Sciences Group Appoints New CEO Company's Board of Directors has appointed Stuart Gold as its Chief Executive Officer. Health Sciences Group Appoints New CEO Company's Board of Directors has appointed Stuart Gold as its Chief Executive Officer. Health Sciences Group Appoints New CEO Company's Board of Directors has appointed Stuart Gold as its Chief Executive Officer. Lifeway Foods Reports Record Second Quarter 2006 Sales Results Company reports sales of $6,365,147 compared to $5,072,567 during the same period a year ago. Lifeway Foods Reports Record Second Quarter 2006 Sales Results Company reports sales of $6,365,147 compared to $5,072,567 during the same period a year ago. Huber Engineered Materials Acquires West Coast Ingredients Huber Engineered Materials, part of J.M. Huber Corporation, today announced the acquisition of West Coast Ingredients in Modesto, Calif. Terms of the deal were not released. Huber Engineered Materials Acquires West Coast Ingredients Huber Engineered Materials, part of J.M. Huber Corporation, today announced the acquisition of West Coast Ingredients in Modesto, Calif. Terms of the deal were not released. Natrol Elects James Peters to Its Board of Directors Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee. Natrol Elects James Peters to Its Board of Directors Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee. Natrol Elects James Peters to Its Board of Directors Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee. Natrol Elects James Peters to Its Board of Directors Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee. Natural Alternatives International, Inc. Announces Fourth Quarter Sales Results and Changes to Executive Team Company announces net sales in excess of $33 million for the three months ended June 30, 2006, surpassing the previous quarterly net sales record set in the fourth quarter of fiscal 2005, and that John Dullea has assumed additional responsibilities as Executive Vice President of NAI and will be responsible for all sales and marketing activities of NAI. Tim Belanger, former Senior Vice President - Sales and Marketing, and Mark Zimmerman, former Vice President - Operations, are no longer with the company. Natural Alternatives International, Inc. Announces Fourth Quarter Sales Results and Changes to Executive Team Company announces net sales in excess of $33 million for the three months ended June 30, 2006, surpassing the previous quarterly net sales record set in the fourth quarter of fiscal 2005, and that John Dullea has assumed additional responsibilities as Executive Vice President of NAI and will be responsible for all sales and marketing activities of NAI. Tim Belanger, former Senior Vice President - Sales and Marketing, and Mark Zimmerman, former Vice President - Operations, are no longer with the company. Nutratech, Inc., Files Patent Infringement Lawsuit Company has filed a patent infringement lawsuit against Syntech International, a nutraceutical ingredient supplier based in Walnut, Calif. Nutratech, Inc., Files Patent Infringement Lawsuit Company has filed a patent infringement lawsuit against Syntech International, a nutraceutical ingredient supplier based in Walnut, Calif. Cognis Completes Acquisition of Omega-3 Fish Oil Company Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry. Cognis Completes Acquisition of Omega-3 Fish Oil Company Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry. Cognis Completes Acquisition of Omega-3 Fish Oil Company Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry. Cognis Completes Acquisition of Omega-3 Fish Oil Company Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry. Cognis Completes Acquisition of Omega-3 Fish Oil Company Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry. New Patent Promotes Soy Isoflavone Benefits The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls. New Patent Promotes Soy Isoflavone Benefits The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls. New Patent Promotes Soy Isoflavone Benefits The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls. Dynamic Health Products, Inc. Reports 2006 Revenue Company reports revenues of $50.1 million, an increase of 212% over the prior year's revenues of $16.1 million, with net income applicable to common shareholders of $5.9 million compared to a net loss of $4.4 million in the prior year. Dynamic Health Products, Inc. Reports 2006 Revenue Company reports revenues of $50.1 million, an increase of 212% over the prior year's revenues of $16.1 million, with net income applicable to common shareholders of $5.9 million compared to a net loss of $4.4 million in the prior year. Schiff Nutrition International, Inc. Announces Fiscal 2006 Fourth Quarter and Year-End Results Company reports net sales of $45.3 million for the three months ended May 31, 2006, compared to $39.9 million for the same period in fiscal 2005, with net income of $6.2 million, or $0.23 per diluted share, versus a net loss of ($1.8) million, or ($0.07) per share, which included an after-tax loss from discontinued operations of ($5.7) million for the same period a year ago. Schiff Nutrition International, Inc. Announces Fiscal 2006 Fourth Quarter and Year-End Results Company reports net sales of $45.3 million for the three months ended May 31, 2006, compared to $39.9 million for the same period in fiscal 2005, with net income of $6.2 million, or $0.23 per diluted share, versus a net loss of ($1.8) million, or ($0.07) per share, which included an after-tax loss from discontinued operations of ($5.7) million for the same period a year ago. Galaxy Nutritional Foods Reports FY2006 Operating Results For the quarter, company reports a net loss of ($1,833,320), or ($0.09) per share, on net sales of approximately $8.4 million, compared with a net loss of ($2,545,790), or ($0.14) per share, and net sales of approximately $10.8 million, in the fourth quarter of the previous fiscal year. Galaxy Nutritional Foods Reports FY2006 Operating Results For the quarter, company reports a net loss of ($1,833,320), or ($0.09) per share, on net sales of approximately $8.4 million, compared with a net loss of ($2,545,790), or ($0.14) per share, and net sales of approximately $10.8 million, in the fourth quarter of the previous fiscal year. Enzymotec and Il Dong Sign Agreement in the Korean Market Israeli biotech company Enzymotec and Korean pharmaceuticals manufacturer Il Dong have announced signing an agreement to launch a novel supplement for CVD prevention in the Korean market. Enzymotec and Il Dong Sign Agreement in the Korean Market Israeli biotech company Enzymotec and Korean pharmaceuticals manufacturer Il Dong have announced signing an agreement to launch a novel supplement for CVD prevention in the Korean market. NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease Natural Products Association Announces Opening of China Office Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace. Natural Products Association Announces Opening of China Office Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace. Natural Products Association Announces Opening of China Office Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace. Natural Products Association Announces Opening of China Office Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace. UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes. UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes. UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes. UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes. USANA Reports Q2 Results Company reports consolidated net sales of $93.9 million, compared with $82.0 million in the second quarter of the prior year, with net earnings of $15.4 million, or 16.4% of net sales, compared with $14.7 million, or 18.0% of net sales, in the second quarter of the prior year. USANA Reports Q2 Results Company reports consolidated net sales of $93.9 million, compared with $82.0 million in the second quarter of the prior year, with net earnings of $15.4 million, or 16.4% of net sales, compared with $14.7 million, or 18.0% of net sales, in the second quarter of the prior year. Allimax Enters Australia Company announces strategic partnership with Vitasearch PTY LTD. Waterloo, NSW for the development and marketing of its Allimax stabilized allicin extract brand of supplements. Allimax Enters Australia Company announces strategic partnership with Vitasearch PTY LTD. Waterloo, NSW for the development and marketing of its Allimax stabilized allicin extract brand of supplements. Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer. Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer. Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer. Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer. Fuji Chemical Granted Inflammation Patent For Astaxanthin Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin. Fuji Chemical Granted Inflammation Patent For Astaxanthin Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin. Fuji Chemical Granted Inflammation Patent For Astaxanthin Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin. Fortitech South America Adds Staff to Address Rapid Premix Sales Growth Fortitech South America has increased its workforce by hiring Rafael Leite as its newest regional sales manager. Leite, who will focus on all Spanish-speaking countries in South America Fortitech South America Adds Staff to Address Rapid Premix Sales Growth Fortitech South America has increased its workforce by hiring Rafael Leite as its newest regional sales manager. Leite, who will focus on all Spanish-speaking countries in South America NSF Vice President Named Adjunct Assistant Professor for Michigan State University NSF Vice President Named Adjunct Assistant Professor for MSU’s Food Science and Human Nutrition Department NSF Vice President Named Adjunct Assistant Professor for Michigan State University NSF Vice President Named Adjunct Assistant Professor for MSU’s Food Science and Human Nutrition Department Lifeway Foods Acquires Helios Kefir Company announces the acquisition of Helios Nutrition Limited, its top competitor in the kefir market with a #2 overall market share and a #1 position in the organic category. Lifeway Foods Acquires Helios Kefir Company announces the acquisition of Helios Nutrition Limited, its top competitor in the kefir market with a #2 overall market share and a #1 position in the organic category. NBTY Reports Third Quarter Results Company reports net sales of $475 million, including $24 million generated by Solgar, compared to net sales of $439 million for the fiscal third quarter prior year, with net income of $30 million, or $0.43 per diluted share, compared to $16 million, or $0.23 per diluted share, for the fiscal third quarter ended June 30, 2005. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	London, England ReGen Therapeutics Plc. ('ReGen'), announces that it has today entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America(the 'Agreement'). ReGen's shares are traded on the AIM Market of the London Stock Exchange plc (RGT) and are quoted on the Pink Sheets of the United States over-the-counter market in the form of American Depositary Receipts (REGUY:PK). Headquartered in San Clemente, California, Metagenics is a leading developer, manufacturer and marketer of nutraceuticals, dedicated to researching and evaluating the effects of natural ingredients on genetic expression and protein activity. The Agreement is conditional on, amongst other things, satisfactory completion of toxicology testing on Colostrinin(TM) and of due diligence by Metagenics on the Colostrinin(TM) manufacturing facilities. Subject to satisfactory completion of the conditions of the Agreement and requisite U.S. regulatory filings, ReGen currently anticipates launch of a human nutraceutical containing Colostrinin(TM)during the first half of 2007. ReGen produces bulk Colostrinin(TM) in South Dakota and will now work with Metagenics to establish the best commercialisation strategy to introduce Colostrinin(TM) into the North American market. The Agreement provides Metagenics with the exclusive right to market Colostrinin(TM) via healthcare professionals with an option to extend this exclusivity into the retail channels, such as drugstores and supermarkets. This option is valid for six months after first launch of a human nutraceutical containing Colostrinin(TM) and is subject to Metagenics being able to identify retail partners acceptable to ReGen and the achievement of certain performance criteria. Percy Lomax, ReGen Executive Chairman and Chief Executive Officer said, 'This agreement with Metagenics is of great significance to ReGen in that it recognises the commercial potential of Colostrinin(TM) in the North American nutraceutical market. After much discussion both parties have decided that the most efficient way to bring this opportunity to fruition is by working together more closely and as an experienced nutraceutical company we see Metagenics as an ideal long-term partner'. Jeff Katke, Chairman and Chief Executive Officer of Metagenics, added, 'We are very pleased to conclude this exclusive licence agreement with ReGen for the introduction of Colostrinin(TM) in North America. ReGen and Metagenics share a commitment to investment in scientific research in order to set new, higher standards of safety and effectiveness of nutraceuticals. Colostrinin(TM) will be an important part of our science-based neurological product line, and we believe it will provide a substantial benefit in maintaining healthy brain function and mental acuity for the ageing patients of over 30,000 healthcare practitioners that we serve in North America.' About ReGen Therapeutics Plc ReGen Therapeutics is a UK listed Biotech company which is developing three business lines - human and veterinary nutraceuticals, prescription pharmaceuticals for the treatment of neurodegenerative diseases and a clinical research organisation which oversees Phase I and Phase II both for ReGen and external customers. ReGen's business strategy is to develop its nutraceutical and pharmaceutical products to a state where they can be licensed out and marketed by a third party. Its only direct sales are currently through its clinical research organisation. www.regentherapeutics.com About Metagenics, Inc. Metagenics, Inc. is a leading developer, manufacturer and marketer of science-based nutraceuticals and medical foods sold to healthcare practitioners worldwide. The company is headquartered in San Clemente, California. with manufacturing and research facilities located in Gig Harbor, Washington- including its MetaProteomics(R) Nutrigenomics Research Center and its Functional Medicine Research Center(SM) for human clinical research. Metagenics holds multiple proprietary formula patents and produces over 400 research-based products to optimize health. Metagenics demonstrates its commitment to purity and quality through its certifications for Good Manufacturing Practices (GMP) from the National Nutritional Foods Association, NSF International, and the Therapeutic Goods Administration of Australia. www.metagenics.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software